Modra

A novel oral formulation technology in oncology to improve delivery and bioavailability of chemotherapy

Switching from intravenous (IV)-to-oral treatment reduces side effects, improves patient convenience and allows options for modern combinatorial cancer treatment regimens

Learn more

News

Phase I results with ModraDoc006/r published in the European Journal of Cancer
Read more

the IV to Oral switch

improving patient lives
Learn more

Events

Meet us at one of the following events:      
Read more